ClinConnect ClinConnect Logo
Search / Trial NCT01488461

Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Dec 6, 2011

Trial Information

Current as of July 21, 2025

Completed

Keywords

Congenital Cerebellar Ataxias Genetics Gene Atcay Gene Abc7 Cerebellar Atrophy

ClinConnect Summary

All patients will be examined by a geneticist or a neuropediatric. All clinical data will be collected.

Strategy of the molecular study :

1. for all multiplex and consanguineous families a linkage analysis (loci ATCAY and ABC7 and others AC known genes) will be performed.
2. For all sporadic patients as well as linked multiplex and consanguineous families : sequencing of all coding exons of the gene ATCAY and others AC known genes.
3. For all sporadic male patients and linked families : sequencing of all coding exons of the gene ABC7.
4. For all patients with suggestive features : sequenc...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patient, child or adult, affected with a congenital or early-onset ataxia defined by:
  • Neurological symptoms observed before age of 2 years.
  • Non progressive cerebellar ataxia observed at the time of examination. Karyotype done or in progress
  • Exclusion Criteria:
  • Metabolic disease
  • Specific MRI malformations suggesting a peculiar entity : molar tooth (joubert syndrome), superior vermis dysplasia with cleft (Oligophrenin)
  • Muscle weakness and elevated creatine phosphokinase (CPK)
  • Clearly progressive ataxia.
  • Absence of signature of the informed consent.
  • Absence of affiliation to social security

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Lydie Burglen, PhD

Principal Investigator

Assistance Publique

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials